| CAT No: | CL-DBFB-35 |
| CAS No: | 1613724-38-1 |
| Mol.F: | C22H16F3N5O5S2 |
| Mol.Wt.: | 551.5 |
| Rel. Cas No: | |
| Chemical Name: | 2-(5-(2-Aminopyrimidin-4-yl)-4-(3-((2,6-difluorophenyl)sulfonamido)-2-fluorophenyl)thiazol-2-yl)-3-hydroxypropanoic acid |
| SMILES: | Smiles Not Available |
| Inventory Status: | Custom synthesis |
This impurity is related to M30-Dabrafenib is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
M30-Dabrafenib is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:2-(5-(2-Aminopyrimidin-4-yl)-4-(3-((2,6-difluorophenyl)sulfonamido)-2-fluorophenyl)thiazol-2-yl)-3-hydroxypropanoic acidCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Dabrafenib Molecular Formula: C22H16F3N5O5S2
Molecular Weight: 551.5
Storage: Store in a cool, dry place.
| Product Name: | M30-Dabrafenib |
| CAS No: | 1613724-38-1 |
| Mol.F.: | C22H16F3N5O5S2 |
| Mol.Wt.: | 551.5 |
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: